CRMD
Price
$12.61
Change
+$0.53 (+4.39%)
Updated
Aug 14 closing price
Capitalization
941.32M
83 days until earnings call
MURA
Price
$1.77
Change
-$0.02 (-1.12%)
Updated
Aug 14 closing price
Capitalization
30.66M
89 days until earnings call
Interact to see
Advertisement

CRMD vs MURA

Header iconCRMD vs MURA Comparison
Open Charts CRMD vs MURABanner chart's image
CorMedix
Price$12.61
Change+$0.53 (+4.39%)
Volume$2.32M
Capitalization941.32M
Mural Oncology
Price$1.77
Change-$0.02 (-1.12%)
Volume$106.26K
Capitalization30.66M
CRMD vs MURA Comparison Chart in %
Loading...
CRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRMD vs. MURA commentary
Aug 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMD is a Hold and MURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 15, 2025
Stock price -- (CRMD: $12.61 vs. MURA: $1.77)
Brand notoriety: CRMD and MURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRMD: 88% vs. MURA: 62%
Market capitalization -- CRMD: $941.32M vs. MURA: $30.66M
CRMD [@Biotechnology] is valued at $941.32M. MURA’s [@Biotechnology] market capitalization is $30.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.07B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRMD’s FA Score shows that 0 FA rating(s) are green whileMURA’s FA Score has 1 green FA rating(s).

  • CRMD’s FA Score: 0 green, 5 red.
  • MURA’s FA Score: 1 green, 4 red.
According to our system of comparison, CRMD is a better buy in the long-term than MURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRMD’s TA Score shows that 6 TA indicator(s) are bullish while MURA’s TA Score has 4 bullish TA indicator(s).

  • CRMD’s TA Score: 6 bullish, 3 bearish.
  • MURA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CRMD is a better buy in the short-term than MURA.

Price Growth

CRMD (@Biotechnology) experienced а +16.65% price change this week, while MURA (@Biotechnology) price change was +5.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.69%. For the same industry, the average monthly price growth was +27.47%, and the average quarterly price growth was +19.86%.

Reported Earning Dates

CRMD is expected to report earnings on Nov 06, 2025.

MURA is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+7.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRMD($941M) has a higher market cap than MURA($30.7M). CRMD YTD gains are higher at: 55.679 vs. MURA (-45.031). CRMD has higher annual earnings (EBITDA): 17.7M vs. MURA (-135.1M). MURA has more cash in the bank: 108M vs. CRMD (77.5M). CRMD has less debt than MURA: CRMD (477K) vs MURA (6.78M). CRMD has higher revenues than MURA: CRMD (82.6M) vs MURA (0).
CRMDMURACRMD / MURA
Capitalization941M30.7M3,065%
EBITDA17.7M-135.1M-13%
Gain YTD55.679-45.031-124%
P/E Ratio16.17N/A-
Revenue82.6M0-
Total Cash77.5M108M72%
Total Debt477K6.78M7%
FUNDAMENTALS RATINGS
CRMD: Fundamental Ratings
CRMD
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
66
SMR RATING
1..100
46
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRMDMURA
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DQEIX13.30N/A
N/A
BNY Mellon Global Equity Income - I
NQCCX4.04N/A
N/A
Nuveen Large Cap Value Opportunities C
FKUTX25.41N/A
N/A
Franklin Utilities A1
BDFUX34.85-0.38
-1.08%
Baron Discovery R6
RSCRX25.64-0.29
-1.12%
Russell Inv US Small Cap Equity R6

CRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRMD has been loosely correlated with MURA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CRMD jumps, then MURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRMD
1D Price
Change %
CRMD100%
+4.39%
MURA - CRMD
36%
Loosely correlated
-1.12%
ARTL - CRMD
33%
Poorly correlated
-0.39%
RLYB - CRMD
32%
Poorly correlated
+1.98%
XLO - CRMD
31%
Poorly correlated
-1.68%
AXON - CRMD
30%
Poorly correlated
-2.05%
More

MURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MURA has been loosely correlated with CRMD. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MURA jumps, then CRMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MURA
1D Price
Change %
MURA100%
-1.12%
CRMD - MURA
37%
Loosely correlated
+4.39%
ACRV - MURA
33%
Poorly correlated
+6.11%
IPSC - MURA
33%
Poorly correlated
+3.15%
IRD - MURA
32%
Poorly correlated
+7.27%
NUVB - MURA
32%
Poorly correlated
+5.75%
More